The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Magnetic nanoparticles: a novel platform for cancer theranostics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Singh, A., Dilnawaz, F., Mewar, S., Sharma, U., Jagannathan, N. R., & Sahoo, S. K. (2011) · ACS Applied Materials & Interfaces · doi:10.1021/am101196v · Cited by 161
Self-citationRetractedToxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Magnetic nanoparticles in MR imaging and drug delivery
Sun, C., Lee, J. S. H., & Zhang, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.018 · Cited by 2,594
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Lee, J.-H., Huh, Y.-M., Jun, Y.-W., Seo, J.-W., Jang, J.-T., Song, H.-T., Kim, S., Cho, E.-J., Yoon, H.-G., Suh, J.-S., et al. (2007) · Nature Medicine · doi:10.1038/nm1467 · Cited by 1,897
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
Veiseh, O., Gunn, J. W., & Zhang, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.002 · Cited by 1,832
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery
Kumar, C. S. S. R., & Mohammad, F. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.008 · Cited by 1,666
Cited by
Lanthanide Nanoparticles: From Design toward Bioimaging and Therapy
Dong, H., Du, S.-R., Zheng, X.-Y., Lyu, G.-M., Sun, L.-D., Li, L.-D., Zhang, P.-Z., Zhang, C., & Yan, C.-H. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00091 · Cited by 1,126
Techniques for physicochemical characterization of nanomaterials
Lin, P.-C., Lin, S., Wang, P. C., & Sridhar, R. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.006 · Cited by 708
Magnetic nanoparticles for environmental and biomedical applications: a review
Mohammed, L., Gomaa, H. G., Ragab, D., & Zhu, J. (2017) · Particuology · doi:10.1016/j.partic.2016.06.001 · Cited by 682
Croissant, J. G., Fatieiev, Y., Almalik, A., & Khashab, N. M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700831 · Cited by 594
Nanotechnology in hyperthermia cancer therapy: From fundamental principles to advanced applications
Beik, J., Abed, Z., Ghoreishi, F. S., Hosseini-Nami, S., Mehrzadi, S., Shakeri-Zadeh, A., & Kamrava, S. K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.062 · Cited by 579
Xie, W., Guo, Z., Gao, F., Gao, Q., Wang, D., Liaw, B.-S., Cai, Q., Sun, X., Wang, X., & Zhao, L. (2018) · Theranostics · doi:10.7150/thno.25220 · Cited by 391
Inorganic nanoparticles: A potential cancer therapy for human welfare
Pugazhendhi, A., Edison, T. N. J. I., Karuppusamy, I., & Kathirvel, B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.034 · Cited by 325
Metal nanoparticles: a theranostic nanotool against cancer
Sharma, H., Mishra, P. K., Talegaonkar, S., & Vaidya, B. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.009 · Cited by 294
The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine
Figueiredo, P., Bauleth-Ramos, T., Hirvonen, J., Sarmento, B., & Santos, H. A. (2018) · Handbook of Nanomaterials for Cancer Theranostics · doi:10.1016/b978-0-12-813339-2.00001-3 · Cited by 287
Nanoparticles-based magnetic and photo induced hyperthermia for cancer treatment
Sharma, S. K., Shrivastava, N., Rossi, F., Tung, L. D., & Thanh, N. T. K. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100795 · Cited by 273
Doped Zinc Oxide Nanoparticles: Synthesis, Characterization and Potential Use in Nanomedicine
Carofiglio, M., Barui, S., Cauda, V., & Laurenti, M. (2020) · Applied Sciences · doi:10.3390/app10155194 · Cited by 262
Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics
Li, K., Nejadnik, H., & Daldrup-Link, H. E. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.04.008 · Cited by 139
Iron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation
Schleich, N., Danhier, F., & Préat, V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.024 · Cited by 124
“5 8 °C) in a defined target volume and also to achieve homogenous heat distributions within the target organ [99].”
BackgroundThe use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices
Hajba, L., & Guttman, A. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.02.001 · Cited by 111
Yang, H. Y., Li, Y., & Lee, D. S. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800011 · Cited by 107
Nowak-Jary, J., & Machnicka, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212013 · Cited by 74
Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment
Viegas, C., Pereira, D. S. M., & Fonte, P. (2022) · Materials · doi:10.3390/ma15062086 · Cited by 21
Biocompatibility and toxicity challenges of nanomaterials
Yaşayan, G., Alarcin, E., Avci-Adali, M., Ipek, T. C., Nejati, O., Özcan-Bülbül, E., Karslı, S., Bal-Öztürk, A., & Mostafavi, E. (2024) · Functionalized Nanomaterials for Cancer Research · doi:10.1016/b978-0-443-15518-5.00019-7 · Cited by 8
Metadata
- Authors
- Singh, A., & Sahoo, S. K.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 19
- Issue
- 4
- Pages
- 474-481
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2043255383
- Cited by
- 289
- References
- 58
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.